Novartis SG&A Expense (Quarterly) Analysis

Novartis AG (NVS)

102.10 +1.90 (+1.89%) USD | NYSE | May 10, 16:00

102.59 +0.48 (+0.48%) After-Hours: 19:27

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2000. Upgrade now.

Date	Value
March 31, 2024	2.84B
December 31, 2023	3.444B
September 30, 2023	3.091B
June 30, 2023	3.686B
March 31, 2023	2.891B
December 31, 2022	3.183B
September 30, 2022	2.936B
June 30, 2022	3.581B
March 31, 2022	3.512B
December 31, 2021	1.926B
September 30, 2021	3.618B
June 30, 2021	3.754B
March 31, 2021	3.529B
December 31, 2020	3.924B
September 30, 2020	3.419B
June 30, 2020	3.368B
March 31, 2020	3.486B
December 31, 2019	3.905B
September 30, 2019	3.549B
June 30, 2019	3.585B
March 31, 2019	3.33B
December 31, 2018	3.677B
September 30, 2018	3.261B
June 30, 2018	3.495B
March 31, 2018	3.284B

Date	Value
December 31, 2017	1.509B
September 30, 2017	3.678B
June 30, 2017	3.806B
March 31, 2017	3.472B
December 31, 2016	3.838B
September 30, 2016	3.40B
June 30, 2016	3.649B
March 31, 2016	3.305B
December 31, 2015	3.885B
September 30, 2015	3.463B
June 30, 2015	3.617B
March 31, 2015	3.282B
December 31, 2014	3.965B
September 30, 2014	3.565B
June 30, 2014	3.826B
March 31, 2014	3.637B
December 31, 2013	4.146B
September 30, 2013	3.674B
June 30, 2013	3.784B
March 31, 2013	4.218B
December 31, 2012	2.467B
September 30, 2012	4.086B
June 30, 2012	4.35B
March 31, 2012	4.214B
December 31, 2011	4.803B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.926B

Minimum

Dec 2021

3.924B

Maximum

Dec 2020

3.361B

Average

3.499B

Median

SG&A Expense (Quarterly) Benchmarks